Justinian Lane

Yet another reason not to support FDA preemption

Another case where the FDA dropped the ball, and Michigan residents have no recourse.

A new analysis links the widely prescribed diabetes drug Avandia to greater risk of heart attack and possibly death.

More than 6 million people worldwide have taken the GlaxoSmithKline drug since it came on the market eight years ago. Pooled results of dozens of studies revealed a 45 percent greater risk of heart attack, according to the analysis, published online Monday by the New England Journal of Medicine…

Several experts said it was another Vioxx-like example of the government failing to detect a safety problem until millions had taken a drug. Vioxx was a blockbuster arthritis medicine until it was withdrawn in 2004 when heart problems came to light.

Source: Diabetes drug linked to heart deaths - Diabetes - MSNBC.com

I wonder how many more mistakes the FDA will have to make before the idea of preemption dies the horrible death it should…

Cross-posted to Corpreform

Posted at 4:00 PM, May 21, 2007 in Federal Preemption | Permalink | Comments (0) | TrackBack (0)